A Phase I Dose Escalating Study of the Safety and Tolerability of Gadolinium Texaphyrin [motexafin gadolinium] as a Radiation Sensitizer in Patients With Primary Glioblastoma Multiforme
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2007
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 10 Jul 2007 Status changed from in progress to completed.
- 02 Oct 2005 New trial record.